Literature DB >> 19148517

Autocrine factors sustain glioblastoma stem cell self-renewal.

Guanghui Li1, Zhengtang Chen, Yi-De Hu, Hong Wei, Dezhi Li, Hua Ji, Dong-Lin Wang.   

Abstract

Glioblastoma stem cells are able to reform original glioblastoma and express the neural stem cell marker CD133 and Nestin. They can self-renew and proliferate in tumor sphere medium containing EGF, bFGF and LIF that is known to be permissive for stem cell proliferation. In this study, we found that neurosphere-like colonies appeared after the human primary glioblastoma cells had been switched into pure DMEM/F12 medium. We investigated whether tumor spheres formed in pure DMEM/F12 medium possess the characteristics of glioblastoma stem cells. We identified that the tumor sphere cells were cancer stem cells of glioblastoma and they can self-renew and proliferate in pure DMEM/F12 medium. Glioblastoma cells can secrete several factors that result in autocrine motility signaling and stimulate glioma invasion. We hypothesized that an essential autocrine signal promotes the self-renewal and proliferation of human glioblastoma stem cells in pure DMEM/F12 medium. Then, expression of EGF and bFGF in glioblastoma stem cells were analyzed. Both the mRNA and protein of EGF and bFGF were detected in three human glioblastoma stem cells. Our findings suggest that autocrine of EGF and bFGF may sustain the self-renewal of glioblastoma stem cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148517

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  Cancer stem-like cells persist in established cell lines through autocrine activation of EGFR signaling.

Authors:  Jeongyub Kim; Jieun Jung; Su-Jae Lee; Jae-Seon Lee; Myung-Jin Park
Journal:  Oncol Lett       Date:  2011-12-21       Impact factor: 2.967

2.  Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines.

Authors:  Seon Ok Min; Sang Woo Lee; Seon Young Bak; Kyung Sik Kim
Journal:  Cancer Cell Int       Date:  2015-10-09       Impact factor: 5.722

Review 3.  Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult.

Authors:  Lidia De Filippis; Elena Binda
Journal:  Stem Cells Transl Med       Date:  2012-04-10       Impact factor: 6.940

Review 4.  The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling.

Authors:  Jamison Beiriger; Ahmed Habib; Nicolina Jovanovich; Chowdari V Kodavali; Lincoln Edwards; Nduka Amankulor; Pascal O Zinn
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 5.  Ribosomes and Ribosomal Proteins Promote Plasticity and Stemness Induction in Glioma Cells via Reprogramming.

Authors:  Takuichiro Hide; Ichiyo Shibahara; Madoka Inukai; Ryota Shigeeda; Toshihiro Kumabe
Journal:  Cells       Date:  2022-07-07       Impact factor: 7.666

6.  Expression of HAUSP in gliomas correlates with disease progression and survival of patients.

Authors:  Chuandong Cheng; Chaoshi Niu; Yang Yang; Yang Wang; Manman Lu
Journal:  Oncol Rep       Date:  2013-03-12       Impact factor: 3.906

7.  Expression of dedifferentiation markers and multilineage markers in U251 glioblastoma cells with silenced EGFR and FGFR genes.

Authors:  Jue Xie; Yue-Hui Ma; Ming Wan; Ren-Ya Zhan; Yong-Qing Zhou
Journal:  Oncol Lett       Date:  2013-11-18       Impact factor: 2.967

Review 8.  Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.

Authors:  Elena Codrici; Ana-Maria Enciu; Ionela-Daniela Popescu; Simona Mihai; Cristiana Tanase
Journal:  Stem Cells Int       Date:  2016-02-10       Impact factor: 5.443

9.  Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.

Authors:  Dian-Gang Chen; Bo Zhu; Sheng-Qing Lv; Hongfan Zhu; Jinliang Tang; Changlin Huang; Qingrui Li; Pu Zhou; Dong-Lin Wang; Guang-Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15

10.  CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.

Authors:  Raheleh Roudi; Zahra Madjd; Marzieh Ebrahimi; Fazel Sahraneshin Samani; Ali Samadikuchaksaraei
Journal:  Cell Mol Biol Lett       Date:  2013-12-23       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.